Trials / Completed
CompletedNCT03058783
Efficacy and Safety of IDP-124 Lotion for the Treatment of Moderate to Severe Atopic Dermatitis in Pediatric and Adult Subjects
A Multicenter, Randomized, Double-Blind, Vehicle-Controlled, Study to Evaluate the Efficacy and Safety of IDP-124 Lotion for the Treatment of Moderate to Severe Atopic Dermatitis in Pediatric and Adult Subjects
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 328 (actual)
- Sponsor
- Bausch Health Americas, Inc. · Industry
- Sex
- All
- Age
- 2 Years
- Healthy volunteers
- Accepted
Summary
Efficacy and Safety of IDP-124 Lotion for the Treatment of Moderate to Severe Atopic Dermatitis in Pediatric and Adult Subjects
Detailed description
A Multicenter, Randomized, Double-Blind, Vehicle-Controlled, Study to Evaluate the Efficacy and Safety of IDP-124 Lotion for the Treatment of Moderate to Severe Atopic Dermatitis in Pediatric and Adult Subjects
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | IDP-124 Lotion | IDP-124 Lotion, twice-daily application |
| DRUG | IDP-124 Vehicle Lotion | IDP-124 Vehicle Lotion, twice-daily application |
Timeline
- Start date
- 2018-08-14
- Primary completion
- 2020-05-12
- Completion
- 2020-05-12
- First posted
- 2017-02-23
- Last updated
- 2023-05-08
- Results posted
- 2023-05-08
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT03058783. Inclusion in this directory is not an endorsement.